AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Varotto, F Di Maria, G Azzaro, R Bellissima, P Amato, R Fogliani, V Muscianisi, G Sabato, V Girbino, G Ando, F Lagana, P Delia, S Jacoviello, C Maierna, G Pezza, A Covelli, I Magri, M Napoletano, G Rossi, A Marone, P Sanguinetti, C Pela, R Tedeschi, D Viola, B Cicciarella, S Messina, G Rizza, S Fraschini, F
Citation: F. Varotto et al., An observational study on the epidemiology of respiratory tract bacterial pathogens and their susceptibility to four injectable beta-lactam antibiotics: Piperacillin, piperacillin/tazobactam, ceftazidime and ceftriaxone, J CHEMOTHER, 13(4), 2001, pp. 413-423

Authors: Mor, M Spadoni, G Di Giacomo, B Diamantini, G Bedini, A Tarzia, G Plazzi, PV Rivara, S Nonno, R Lucini, V Pannacci, M Fraschini, F Stankov, BM
Citation: M. Mor et al., Synthesis, pharmacological characterization and QSAR studies on 2-substituted indole melatonin receptor ligands, BIO MED CH, 9(4), 2001, pp. 1045-1057

Authors: Spadoni, G Balsamini, C Diamantini, G Tontini, A Tarzia, G Mor, M Rivara, S Plazzi, PV Nonno, R Lucini, V Pannacci, M Fraschini, F Stankov, BM
Citation: G. Spadoni et al., 2-N-acylaminoalkylindoles: Design and quantitative structure-activity relationship studies leading to MT2-selective melatonin antagonists, J MED CHEM, 44(18), 2001, pp. 2900-2912

Authors: Nonno, R Lucini, V Spadoni, G Pannacci, M Croce, A Esposti, D Balsamini, C Tarzia, G Fraschini, F Stankov, BM
Citation: R. Nonno et al., A new melatonin receptor ligand with mt(1)-agonist and MT2-antagonist properties, J PINEAL R, 29(4), 2000, pp. 234-240

Authors: Pagani, G Pregnolato, M Ubiali, D Terreni, M Piersimoni, C Scaglione, F Fraschini, F Gascon, AR Munoz, JLP
Citation: G. Pagani et al., Synthesis and in vitro anti-Mycobacterium activity of N-alkyl-1,2-dihydro-2-thioxo-3-pyridinecarbothioamides. Preliminary toxicity and pharmacokinetic evaluation, J MED CHEM, 43(2), 2000, pp. 199-204

Authors: Scaglione, F Demartini, G Dugnani, S Fraschini, F
Citation: F. Scaglione et al., In vitro comparative dynamics of modified-release clarithromycin and of azithromycin, CHEMOTHERA, 46(5), 2000, pp. 342-352

Authors: Scaglione, F Demartini, G Dugnani, S Arcidiacono, MM Pintucci, JP Fraschini, F
Citation: F. Scaglione et al., Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin, BR J CL PH, 47(3), 1999, pp. 267-271

Authors: Varotto, F Parravidini, E De Luca, M Casini, A Fraschini, F
Citation: F. Varotto et al., In vitro antibacterial activity of men 10700, a new penem antibiotic, CHEMOTHERA, 45(6), 1999, pp. 405-410

Authors: Nonno, R Pannacci, M Lucini, V Angeloni, D Fraschini, F Stankov, BM
Citation: R. Nonno et al., Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt(1)-antagonists, BR J PHARM, 127(5), 1999, pp. 1288-1294

Authors: Spadoni, G Balsamini, C Bedini, A Carey, A Diamantini, G Di Giacomo, B Tontini, A Tarzia, G Nonno, R Lucini, V Pannacci, M Stankov, BM Fraschini, F
Citation: G. Spadoni et al., N-acyl-5- and -2,5-substituted tryptamines: Synthesis, activity and affinity for human mt(1) and MT2 melatonin receptors, MED CHEM RE, 8(9), 1998, pp. 487-498

Authors: Leone, M Lucini, V D'Amico, D Grazzi, L Moschiano, F Fraschini, F Bussone, G
Citation: M. Leone et al., Abnormal 24-hour urinary excretory pattern of 6-sulphatoxymelatonin in both phases of cluster headache, CEPHALALGIA, 18(10), 1998, pp. 664-667
Risultati: 1-11 |